Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roy H Perlis

Showing results (81-90 of 414) with videos related to

Pageof 42
Sort By:
Medrxiv : the Preprint Server for Health Sciences|March 10, 2021
Consistency of performance of adverse outcome prediction models for hospitalized COVID-19 patientsVictor M Castro, Thomas H McCoy, Roy H Perlis
JAMA Network Open|July 27, 2021
Assessment of the Performance Consistency of an Adverse Outcome Prediction Tool for Patients Hospitalized With COVID-19Victor M Castro, Thomas H McCoy, Roy H Perlis
The Journal of Clinical Psychiatry|August 8, 2008
Clinical insights into pharmacogenetics and schizophrenia, part 2John M Kane, Roy H Perlis, Anil K Malhotra
Journal of the Academy of Consultation-Liaison Psychiatry|July 2, 2021
Mapping of Transdiagnostic Neuropsychiatric Phenotypes Across Patients in Two General HospitalsKamber L Hart, Roy H Perlis, Thomas H McCoy
Plos One|August 26, 2020
Differences among Research Domain Criteria score trajectories by Diagnostic and Statistical Manual categorical diagnosis during inpatient hospitalizationThomas H McCoy, Amelia M Pellegrini, Roy H Perlis
Medrxiv : the Preprint Server for Health Sciences|February 13, 2023
Correlates of symptomatic remission among individuals with post-COVID-19 conditionRoy H Perlis, Mauricio Santillana, Katherine Ognyanova, et al.
JAMA Network Open|November 18, 2025
Barriers and Solutions to Efficient Health Care AI ImplementationKatherine Musacchio Schafer, Jacob Franklin, Roy H Perlis, et al.
Pharmacogenomics|January 20, 2012
Biomarkers predicting treatment outcome in depression: what is clinically significant?Rudolf Uher, Katherine E Tansey, Karim Malki, et al.
Depression and Anxiety|November 26, 2013
Major depressive disorder in DSM-5: implications for clinical practice and research of changes from DSM-IVRudolf Uher, Jennifer L Payne, Barbara Pavlova, et al.
Plos One|October 3, 2012
Copy number variation in subjects with major depressive disorder who attempted suicideRoy H Perlis, Douglas Ruderfer, Steven P Hamilton, et al.
Pageof 42

Showing results (81-90 of 414) with videos related to

Sort By:
Pageof 42
Medrxiv : the Preprint Server for Health Sciences|March 10, 2021
Consistency of performance of adverse outcome prediction models for hospitalized COVID-19 patientsVictor M Castro, Thomas H McCoy, Roy H Perlis
JAMA Network Open|July 27, 2021
Assessment of the Performance Consistency of an Adverse Outcome Prediction Tool for Patients Hospitalized With COVID-19Victor M Castro, Thomas H McCoy, Roy H Perlis
The Journal of Clinical Psychiatry|August 8, 2008
Clinical insights into pharmacogenetics and schizophrenia, part 2John M Kane, Roy H Perlis, Anil K Malhotra
Journal of the Academy of Consultation-Liaison Psychiatry|July 2, 2021
Mapping of Transdiagnostic Neuropsychiatric Phenotypes Across Patients in Two General HospitalsKamber L Hart, Roy H Perlis, Thomas H McCoy
Plos One|August 26, 2020
Differences among Research Domain Criteria score trajectories by Diagnostic and Statistical Manual categorical diagnosis during inpatient hospitalizationThomas H McCoy, Amelia M Pellegrini, Roy H Perlis
Medrxiv : the Preprint Server for Health Sciences|February 13, 2023
Correlates of symptomatic remission among individuals with post-COVID-19 conditionRoy H Perlis, Mauricio Santillana, Katherine Ognyanova, et al.
JAMA Network Open|November 18, 2025
Barriers and Solutions to Efficient Health Care AI ImplementationKatherine Musacchio Schafer, Jacob Franklin, Roy H Perlis, et al.
Pharmacogenomics|January 20, 2012
Biomarkers predicting treatment outcome in depression: what is clinically significant?Rudolf Uher, Katherine E Tansey, Karim Malki, et al.
Depression and Anxiety|November 26, 2013
Major depressive disorder in DSM-5: implications for clinical practice and research of changes from DSM-IVRudolf Uher, Jennifer L Payne, Barbara Pavlova, et al.
Plos One|October 3, 2012
Copy number variation in subjects with major depressive disorder who attempted suicideRoy H Perlis, Douglas Ruderfer, Steven P Hamilton, et al.
Pageof 42